Literature DB >> 6486138

Mammographic parenchymal patterns and risk of breast cancer in postmenopausal women.

R I Horwitz, A M Lamas, D Peck.   

Abstract

A case-control study was conducted to assess whether certain "high-risk" mammographic parenchymal patterns are associated with the increased occurrence of breast cancer in postmenopausal women. Patients in the case group included 105 women with histologically confirmed breast cancer; subjects in the control group included 104 women with fibrocystic breast disease and 103 women with clinically normal breasts. All mammographic results were evaluated "blindly" by a radiologist who classified the breast parenchyma into "high-risk" and "low-risk" categories according to the criteria proposed by Wolfe. These data showed a similar proportion of allegedly "high-risk" breast parenchymal patterns among patients in all three groups. The finding that breast parenchymal patterns are not associated with an increased risk of breast cancer in women 50 years of age or older is consistent with the results of earlier studies in which the association is present only in younger, premenopausal women, and is absent in older, predominantly postmenopausal women. Consequently, it is concluded that these parenchymal patterns should not be used to select postmenopausal women for breast cancer screening programs, or to guide the evaluation of postmenopausal women with breast lumps or symptoms.

Entities:  

Mesh:

Year:  1984        PMID: 6486138     DOI: 10.1016/0002-9343(84)90351-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  2 in total

Review 1.  Mammographic density is not a worthwhile examination to distinguish high cancer risk women in screening.

Authors:  Catherine Colin; Anne-Marie Schott; Pierre-Jean Valette
Journal:  Eur Radiol       Date:  2014-06-28       Impact factor: 5.315

2.  Interaction of dense breast patterns with other breast cancer risk factors in a case-control study.

Authors:  S W Duffy; R W Jakes; F C Ng; F Gao
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.